Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
about
The H19 non-coding RNA is essential for human tumor growthmiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerFilopodia and adhesion in cancer cell motilityTunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesotheliomaA novel Rho-dependent pathway that drives interaction of fascin-1 with p-Lin-11/Isl-1/Mec-3 kinase (LIMK) 1/2 to promote fascin-1/actin binding and filopodia stability.Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasisFascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation.Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade.Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MSFascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells.Fascin expression in colorectal carcinomas.Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma.Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypesDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.Fascin promotes the motility and invasiveness of pancreatic cancer cells.Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma.Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expressionFascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.Fascin expression predicts an aggressive clinical course in patients with advanced breast cancer.Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer.Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer.The role of fascin in the migration and invasiveness of malignant glioma cells.Regulation and functional significance of CDC42 alternative splicing in ovarian cancerFascin expression in human embryonic, fetal, and normal adult tissue.Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinomamiR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysisThe prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.Fascin1 in carcinomas: Its regulation and prognostic value.Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancer.Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling.Monoubiquitination Inhibits the Actin Bundling Activity of Fascin.
P2860
Q21144433-81088948-FBFF-4BDF-BF29-B4A38F25D2AAQ24632886-1D3BBC00-9E97-482C-AAF9-4FB1EFFD087AQ26823315-7D3EF5BA-E347-4CFC-8336-2E9BCAB93081Q27307288-E5E9B1AE-A7A8-4568-9B08-FD665CEFAA88Q30424110-78DE7815-F289-4CFB-9573-742E781D4353Q30480311-334A4E12-30E1-4928-B02B-62A8CAC42717Q30570724-71E5F939-C463-4782-8595-D9D22AEF6063Q30572690-994C1F10-534A-47F4-80FA-9BFEA40E07FCQ33259830-C7733C2D-D4EB-4443-B33B-E08C576F2DBAQ33274389-8DABFF3A-7FB8-47A3-96A0-A56050ED4AC4Q33280569-071DF2A1-E452-4C5F-97FD-10561BF0F97AQ33419602-C12E5CAD-77FC-460E-8F23-D08F3A14A42BQ33425930-7119CC4D-FE76-41BE-8503-E53EC9C87DCDQ33684686-A7234566-0B62-428A-A6C5-3124EBD4AB4CQ33904564-7C2C965A-6EA1-4D42-841F-B36C17E13CAFQ34134515-B0C7B1BF-40C7-4001-9F1B-1539B6EEEED7Q34217013-E9DDF7E3-6FEA-4A50-890F-3AD3C938483BQ34500644-064441FF-0B51-4F15-8E8C-80418D2AB90DQ34917292-DCDFF159-F8E8-431B-9E5E-EA2E87910024Q34972287-46E6A5CB-2531-4A6F-A812-9E87A02DEC56Q35555679-9B64B985-3AEB-4FD0-A17B-85B932BE162CQ35608138-715A010B-0B06-42D6-9154-2462AC6C5C37Q35688177-09BE2BBD-F2E0-4880-BD88-B81988F59840Q35770332-6600FDD1-724D-487C-B984-4DB0EBCE2BA0Q35803396-156728BD-AA4E-48D5-88D0-8BD1AAD931D6Q35822059-97B3E47B-7CDA-4B27-8EFD-EFF8FD26B67AQ36116616-6F050DAF-5A7B-453A-8D58-6150FFD72CFAQ36462821-1DBF3306-D290-4D90-A53D-E07EA5915A7EQ36557397-ABCD4387-B616-449C-900D-AE7B7899499DQ36572839-7DA10046-BE32-420F-A3E6-B3B981A4F758Q36610155-12ED80CF-BFEF-451E-B3BC-56EC0A574FA5Q36658350-018424B1-F6EE-45AC-AF08-5012D6353B20Q36793866-D29CECFF-4BF9-4D8E-8C12-67E358A33EB0Q36965068-923DDEC6-3BF2-4BB8-BD33-02DB3B481DBCQ37591952-846777B2-9DC1-4E09-9749-EB5F3BDB2764Q38258787-8FBA1EF8-1E3B-4EAC-9C6C-D3A3783A3160Q38331911-F19B31DC-7C08-4172-B503-9E1671970DDDQ38418735-ED24619E-76BC-4B16-9996-441FFABCB10BQ38793478-0EDA8059-05FA-4719-A019-8C35BD1E1D97Q39159697-BDED78BC-35A2-43BC-9176-D06CA46A10BD
P2860
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@ast
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@en
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@nl
type
label
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@ast
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@en
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@nl
prefLabel
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@ast
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@en
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@nl
P2093
P2860
P356
P1476
Independent prognostic value o ...... ge I nonsmall cell lung cancer
@en
P2093
A Iannucci
A Sonzogni
E Bresaola
F Fraggetta
F Pezzella
G De Manzoni
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600731
P407
P577
2003-02-24T00:00:00Z
P5875
P6179
1052736377